PeraHealth Secures $14M Series A to Advance Real-Time Hospital-Wide Patient Deterioration Alerts

PeraHealth is a healthcare data analytics company headquartered in North Carolina. Founded in 2008, the company secured $14 million in its first round of financing on January 9. The investor was Mainsail Partners, a growth equity firm. PeraHealth has developed an algorithmic system that identifies at-risk patients and enables early intervention through predictive, real-time clinical monitoring solutions, primarily serving hospital clients.

“PeraHealth is a clinical decision support company. We provide patient monitoring tools and systems to hospitals, enabling true patient monitoring and capturing potentially severe adverse events,” revealed Stephanie Alexander, CEO of PeraHealth, in a media interview following the financing round. “For example, our early warning system for sepsis allows us to monitor all patients across the entire hospital. These tools are embedded directly within the EHR software of all health systems, so physicians, nurses, and other clinicians can receive alerts and intervene early.”

In terms of product type,The core is based onRothman Index System,The company offers a suite of monitoring and analytics tools, including PeraMobile, which promptly sends risk alerts and patient data to care providers. PeraHealth’s greatest advantage lies in its ability to generate early warnings based on data already available in the Electronic Health Record (EHR). As the system is accessible through the EHR, it does not impose additional steps or workflow burdens on providers.

PeraHealth's Four Core Tools

When discussing the company’s advantages over similar competitors, Stephanie Alexander stated, “Our early warning system is more timely; for instance, it can detect deterioration 24 to 48 hours earlier than other systems, and in some cases, up to seven days in advance. As a result, we can eliminate the need to dispatch physicians to assess patients’ conditions. The system has become highly intelligent. This also aligns with the current trend in broad health and wellness, where leading healthcare organizations are achieving significant value-based performance improvements.”

As a growth equity investor, Mainsail Partners will provide the company with substantial hands-on support, including access to its robust operating team and extensive healthcare and technology expertise.

Major Hospitals and Institutions Partnering with PeraHealth

Currently, PeraHealth collaborates with more than 80 hospitals, encompassing a diverse range of clients: academic medical centers such as Yale New Haven Hospital, children’s hospitals like the Children’s Hospital of Philadelphia, larger health systems such as Houston Methodist, and smaller community health systems. Other clients include Memorial Sloan Kettering Cancer Center and Mission Health. The system is compatible with mainstream electronic health records (EHRs). Notably, impactful interventions have demonstrated a 30% reduction in mortality within 12 months at the San Rafael campus, and a reduction in sepsis-related mortality within nine months at Bridgeport Hospital.Reduce29％

“Our focus is on providing hospitals with more resources to achieve better outcomes,” said Alexander. “Our health system has documented an average 40% reduction in mortality rates. To maximize the adoption of PeraHealth’s tools by hospitals, the post-financing efforts will not only improve the quality of services provided but also enhance algorithm development for other personalized services.”